Contrast-Enhanced MRI of the renal arteries

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-023002-13

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to evaluate the efficacy of gadobutrol-enhanced MRA over 2D-ToF MRA in subjects with known or suspected renal artery disease, as verified by - superiority for structural delineation, - non-inferiority for the detection of clinically significant vascular disease, - non-inferiority for the exclusion of clinically significant vascular disease, - minimum performance for gadobutrol detection of clinically significant vascular disease, and - minimum performance for gadobutrol exclusion of clinically significant vascular disease using CTA as the SoR excluding the first objective, structural delineation.


Critère d'inclusion

  • Subjects with known or suspected renal artery disease